GRCL   $10.25  0.05% Market Closed

Gracell Biotechnologies Inc
Total Cash 1.71B
totalCashPerShare 3.561
EBITDA -509.64M
Total Debt 115.82M
quickRatio 7.442
currentRatio 7.732
Total Revenue
debtToEquity 7.145
Revenue/Share
ROA -0.19406
ROE -0.31574
grossProfits
freeCashflow
operatingCashflow
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 3.32B
forwardPE -56.944443
floatShares 165.04M
sharesOutstanding 96.57M
sharesShort 1.19M
sharesShortPriorMonth 554.38K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.16%
heldPercentInstitutions 0.63%
Short Ratio help_outline 0.87%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 16.899
Price To Book help_outline 0.61
earningsQuarterlyGrowth
netIncomeToCommon -496.98M
trailingEps -0.97%
forwardEps -0.18%
enterpriseToEbitda -6.52
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.04 4Q 2023
institutionsCount 82
lastUpdated April 1, 2024, 2:56 p.m.